Profile: Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. We provide Arcalyst® (rilonacept) injection for subcutaneous use for the treatment of a rare, inherited, inflammatory condition. We are involved in the treatment of cancer, eye diseases, inflammatory diseases, & pain, and have preclinical programs in other diseases & disorders.
The company was founded in 1988, has revenues of USD 10-25 Million, has ~590 employees. NASDAQ:REGN (SEC Filings)
3 Products/Services (Click for related suppliers)
|
• Pharmaceutical Sterilizers |
• Pharmaceuticals |
• Pharmaceuticals/Chemicals Contract Manufacturing |